From Lyle Petersen’s letter addressed to Carl Tuttle on Feb 15, 2012:
“We welcome the opportunity to respond to a statement in one of your letters, which repeats a common misrepresentation of the facts regarding CDC’s work in development of Lyme disease diagnostics. In your letter you state, “Those of us who have been harmed by the two tier testing algorithm find it a conflict of interest when the Director of the CDC’ strongly recommends’ only FDA-approved antibody tests for the diagnosis of Lyme disease especially when employees of the CDC (Barbara Johnson) hold patent interests in these faulty tests.” Your allegation that CDC program staff, including Dr. Barbara Johnson, hold patents on Lyme diagnostics and/or have financial conflicts of interest is false”
“More than a decade ago, Dr. Johnson was listed as an inventor on two patent applications and foreign filings related to specific antigens of Borrelia burgdorferi. These applications were made in accordance with government policy to protect the investment of taxpayers in government directed research. [??? Emphasis added]
Subsequent work indicated that these antigens were not as diagnostically useful as alternatives discovered by others, such as the C6 peptide. Consequently, both patent applications and their associated foreign filings were abandoned in February, 1997 and November, 2003. Dr. Johnson never received any payments related to these applications, and she does not hold patents that could generate such payments. She is not an inventor of the C6 peptide assay, as alleged by some, and receives no royalties from this invention. In fact, no CDC employees have ever received payments, royalties, or consulting fees for any activity related to commercial tests or vaccines for Lyme disease.”
The entire letter is posted here: (free to distribute)
Carl Tuttle follow-up letter to Mary Beth in response to Lyle Petersen’s “opinion” piece to the Poughkeepsie Journal’s interest in reporting on Lyme disease.
85 Civic Center Plaza
Poughkeepsie, NY 12601
Attn: Mary Beth Pfeiffer
Dear Mary Beth,
Thank you for your continued efforts in covering the Lyme disease epidemic. In reference to the recent reply from the CDC’s Lyle R. Petersen I would like to point out that once again (as always) there is an emphasis on the acute stage of the disease.
I fall under the category of patients who had a “prolonged exposure to the organism prior to the initial diagnosis and antibiotic treatment of Lyme disease” as it took twelve years to obtain a diagnosis. Late stage Lyme disease does not respond well to antibiotics and it is this stage of the disease where “elements of academic medicine, elements of government and virtually the entire insurance industry have colluded to deny a disease.”
It is blatantly obvious that individuals who control public health policy for Lyme disease are either incredibly incompetent or committed to precisely what has been orchestrated to deny the late stage Lyme epidemic seen all across this nation.
Case in point: New York Medical College’s Lyme diagnostic center. (Gary Wormser’s location and co-author of the insurance friendly IDSA treatment guidelines) Below is a copy of their home page. Apparently Late Stage Lyme doesn’t exist as it is not listed on their website, additional evidence of the ongoing/blatant denial of the late manifestation of the Lyme disease epidemic.
Lyme Disease Diagnostic Center at New York Medical College
Background and Mission Statement: Established in 1989, the Lyme Disease Diagnostic Center is staffed by experienced physicians and nurses with special expertise in the diagnosis and treatment of persons 18 years and older with: – Tick bites – Early/Acute Lyme disease – Anaplasmosis (Ehrlichiosis) – Babesiosis ——————————————————- Since we only test for antibodies against the infection and not the bacteria itself, we have no way to rule out active, continuing infection (until now) which has been ideal for the “chronic Lyme” denialist camp headed up by Alan Steere and colleagues.
His nearly forty year old “theory” (Infection-induced autoimmunity) has yet to be substantiated but plays a large role in the treatment and insurance reimbursement denial of countless patients across the country. The denial of this epidemic and refusal to reimburse for treating persistent infection has caused untold pain and suffering not only in New Hampshire but across the nation.
Johns Hopkins published a study that followed patients who were treated from an acute Lyme disease stage but went on to develop debilitating symptoms after the standard IDSA treatment protocol. 35% of patients met the definition of post-Lyme syndrome 6 months after treatment and as many as 45% with one major symptom.
I have suggested to Dr Aucott he test these patients using Advanced Laboratory Services’ Borellia Culture test.
We now have proof that chronic Lyme exists through Advanced Laboratory Services’s Borrellia culture test as the laboratory is reporting positive cultures in 80% of symptomatic post treatment Lyme patient specimens so why is the CDC in no rush whatsoever to embrace this technology? Because the true epidemic and deceitful handling of late stage Lyme disease will finally be exposed!
Sincerely, Carl Tuttle